Safety of aripiprazole: High serum levels in a CYP2D6 mutated patient

被引：12

作者：

Oosterhuis, Marieke

de Kraats, Gerben Van

Tenback, Diederik

机构：

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 2007年 / 164卷 / 01期

关键词：

D O I：

10.1176/appi.ajp.164.1.175

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：175 / 175

页数：1

共 6 条

[1]

*BRIST MYERS SQUIB, 2004, AR SUMM PROD CHAR

[2] Overdose of aripiprazole, a new type of antipsychotic [J].

Carstairs, SD ;

Williams, SR .

JOURNAL OF EMERGENCY MEDICINE, 2005, 28 (03) :311-313

[3] GENETIC-BASIS FOR A LOWER PREVALENCE OF DEFICIENT CYP2D6 OXIDATIVE DRUG-METABOLISM PHENOTYPES IN BLACK-AMERICANS [J].

EVANS, WE ;

RELLING, MV ;

RAHMAN, A ;

MCLEOD, HL ;

SCOTT, EP ;

LIN, JS .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2150-2154

[4] Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal, healthy volunteers [J].

Mallikaarjun, S ;

Salazar, DE ;

Bramer, SL .

JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (02) :179-187

[5] PM frequencies of major CYPs in Asians and Caucasians [J].

Mizutani, T .

DRUG METABOLISM REVIEWS, 2003, 35 (2-3) :99-106

[6] Concordance of the toxicity of pharmaceuticals in humans and in animals [J].

Olson, H ;

Betton, G ;

Robinson, D ;

Thomas, K ;

Monro, A ;

Kolaja, G ;

Lilly, P ;

Sanders, J ;

Sipes, G ;

Bracken, W ;

Dorato, M ;

Van Deun, K ;

Smith, P ;

Berger, B ;

Heller, A .

REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2000, 32 (01) :56-67

← 1 →